384 related articles for article (PubMed ID: 25066040)
1. Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee.
Raje N; Faiman B; Harvey RD; Kurtin SE; Lonial S; Kumar SK; Cohen AD; Conde MA; Giralt SA; Recine MS; Tombler ER; Stadtmauer E; Jagannath S; Anderson KC;
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):356-69. PubMed ID: 25066040
[TBL] [Abstract][Full Text] [Related]
2. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
3. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop.
Tan D; Lee JH; Chen W; Shimizu K; Hou J; Suzuki K; Nawarawong W; Huang SY; Sang Chim C; Kim K; Kumar L; Malhotra P; Chng WJ; Durie B;
Leuk Lymphoma; 2018 Oct; 59(10):2305-2317. PubMed ID: 29390932
[TBL] [Abstract][Full Text] [Related]
5. Barriers to physician adherence to evidence-based monitoring guidelines in chronic myelogenous leukemia.
Goldberg SL; Akard LP; Dugan MJ; Faderl S; Pecora AL
J Oncol Pract; 2015 May; 11(3):e398-404. PubMed ID: 25758446
[TBL] [Abstract][Full Text] [Related]
6. Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.
Samaras P; Bargetzi M; Betticher DC; Duchosal MA; Heim D; Hess U; Ketterer N; Lerch E; Matthes T; Mey U; Pabst T; Taverna C; Zander T; Renner C
Swiss Med Wkly; 2015; 145():w14100. PubMed ID: 25999239
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in Older Adults.
Guerard EJ; Tuchman SA
Clin Geriatr Med; 2016 Feb; 32(1):191-205. PubMed ID: 26614868
[TBL] [Abstract][Full Text] [Related]
8. [Multiple myeloma: New criteria for diagnosis and treatment, strong therapeutic hopes].
Manier S; de Charette de la Contrie M; Hieulle J; Daniel A; Facon T
Presse Med; 2019; 48(7-8 Pt 1):825-831. PubMed ID: 31447337
[TBL] [Abstract][Full Text] [Related]
9. American Society of Hematology Annual Meeting 2014: highlights in multiple myeloma.
Glavey SV; Ghobrial IM
Expert Rev Hematol; 2015 Jun; 8(3):273-5. PubMed ID: 25804827
[TBL] [Abstract][Full Text] [Related]
10. Estimate of multiple myeloma patients by line of therapy in the USA: population-level projections 2020-2025.
Kanas G; Clark O; Keeven K; Nersesyan K; Sansbury L; Hogea C
Future Oncol; 2021 Mar; 17(8):921-930. PubMed ID: 33200616
[No Abstract] [Full Text] [Related]
11. Asymptomatic monoclonal gammopathies.
Bories C; Jagannath S
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S78-86. PubMed ID: 25486961
[TBL] [Abstract][Full Text] [Related]
12. Multiple myeloma: epidemiology and therapeutic options.
Tuscano JM
Manag Care; 2008 Jul; 17(7 Suppl 6):9-15. PubMed ID: 19093334
[TBL] [Abstract][Full Text] [Related]
13. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
Kyle RA
Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
[TBL] [Abstract][Full Text] [Related]
14. [Modern treatment methods for multiple myeloma: guidelines from the Dutch Haemato-Oncology Association (HOVON)].
Lokhorst H; Huijgens PC; Raymakers R; Bos GM; Vellenga E; Wijermans PW; Sonneveld P;
Ned Tijdschr Geneeskd; 2005 Apr; 149(15):808-13. PubMed ID: 15850271
[TBL] [Abstract][Full Text] [Related]
15. [Management of multiple myeloma in Hungary in 2016].
Varga G; Mikala G; Váróczy L; Illés Á
Orv Hetil; 2016 Jan; 157(4):123-37. PubMed ID: 26772825
[TBL] [Abstract][Full Text] [Related]
16. Overview of recent trends in diagnosis and management of leptomeningeal multiple myeloma.
Yellu MR; Engel JM; Ghose A; Onitilo AA
Hematol Oncol; 2016 Mar; 34(1):2-8. PubMed ID: 25524637
[TBL] [Abstract][Full Text] [Related]
17. Educational needs in the diagnosis and management of pediatric functional constipation: a US survey of specialist and primary care clinicians.
Barnes J; Coleman B; Hwang S; Stolic A; Bousvaros A; Nurko S; Salinas GD
Postgrad Med; 2018 May; 130(4):428-435. PubMed ID: 29667860
[TBL] [Abstract][Full Text] [Related]
18. [Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].
Shimizu K;
Rinsho Ketsueki; 2005 Jun; 46(6):424-32. PubMed ID: 16447724
[No Abstract] [Full Text] [Related]
19. [Application and safety of thalidomide in the treatment of multiple myeloma].
Hattori Y
Nihon Rinsho; 2007 Dec; 65(12):2296-301. PubMed ID: 18069276
[TBL] [Abstract][Full Text] [Related]
20. Continuing medical education effect on practice performance: effectiveness of continuing medical education: American College of Chest Physicians Evidence-Based Educational Guidelines.
Davis D; Galbraith R;
Chest; 2009 Mar; 135(3 Suppl):42S-48S. PubMed ID: 19265075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
